skin was tingling as if all his nerves were hyperactive/ tingling in skin against cloting (esp. in legs); Fatigue; body aches/muscle sensitivity; Fever; Joint pain/walking home his joints ached; Headache; joint stiffness; constant feeling of needing the bathroom; feeling of hunger and tingling in skin against cloting (esp. in legs); Loss of appetite and taste for certain foods; Loss of appetite and taste for certain foods; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (skin was tingling as if all his nerves were hyperactive/ tingling in skin against cloting (esp. in legs)), JOINT STIFFNESS (joint stiffness), MICTURITION URGENCY (constant feeling of needing the bathroom), HUNGER (feeling of hunger and tingling in skin against cloting (esp. in legs)) and AGEUSIA (Loss of appetite and taste for certain foods) in a 33-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Feeling hot (after dose 1 of mRNA-1273) on 02-May-2021 and Temperature regulation disorder NOS (after dose 1 of mRNA-1273).   On 27-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In May 2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced JOINT STIFFNESS (joint stiffness), MICTURITION URGENCY (constant feeling of needing the bathroom), HUNGER (feeling of hunger and tingling in skin against cloting (esp. in legs)), AGEUSIA (Loss of appetite and taste for certain foods), DECREASED APPETITE (Loss of appetite and taste for certain foods), ARTHRALGIA (Joint pain/walking home his joints ached) and HEADACHE (Headache). On 26-May-2021, the patient experienced PARAESTHESIA (skin was tingling as if all his nerves were hyperactive/ tingling in skin against cloting (esp. in legs)), FATIGUE (Fatigue), MYALGIA (body aches/muscle sensitivity) and PYREXIA (Fever). The patient was treated with ACETAMINOPHEN in May 2021 at a dose of 1 dosage form. On 28-May-2021, PARAESTHESIA (skin was tingling as if all his nerves were hyperactive/ tingling in skin against cloting (esp. in legs)), FATIGUE (Fatigue), MYALGIA (body aches/muscle sensitivity) and PYREXIA (Fever) had resolved. On 02-Jul-2021, JOINT STIFFNESS (joint stiffness), MICTURITION URGENCY (constant feeling of needing the bathroom), HUNGER (feeling of hunger and tingling in skin against cloting (esp. in legs)), AGEUSIA (Loss of appetite and taste for certain foods), DECREASED APPETITE (Loss of appetite and taste for certain foods), ARTHRALGIA (Joint pain/walking home his joints ached) and HEADACHE (Headache) had resolved.            No concomitant medications were provided.    This case was linked to MOD-2021-200203 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 02-Jul-2021: contains significant information such as patient demographic information, treatment drug updated, events outcome and end date.